Inhibition of Tissue Factor Pathway During Intermittent Pneumatic Compression
Authors:
- 1 November 1999
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (11) , 2812-2817
Abstract
—Intermittent pneumatic compression (IPC) devices are an effective prophylaxis against lower extremity deep vein thrombosis. Their antithrombotic effect has been attributed to a reduction in venous stasis and enhanced fibrinolysis. The initiating mechanism for blood coagulation is the tissue factor (TF) dependent pathway, which is inhibited by tissue factor pathway inhibitor (TFPI). We have investigated the effect of IPC on the TF pathway in 6 normal subjects and 6 patients with postthrombotic venous disease undergoing IPC for 120 minutes; all subjects were studied with each of 5 IPC devices. In normal subjects and patients, plasma factor VIIa (FVIIa) activity (the activated form of factor VII [FVII]) declined from mean values ranging 51 to 65 and 50 to 53 mU/mL before IPC with different devices to 10 to 13 and 20 to 22 mU/mL at 180 minutes, respectively ( P P P r =−0.31, P =0.001) and patients ( r =−0.37, P <0.001). IPC results in an increase in plasma TFPI and decline in FVIIa. Inhibition of TF pathway, the initiating mechanism of blood coagulation, is a possible mechanism for the antithrombotic effect of IPC.Keywords
This publication has 27 references indexed in Scilit:
- The Fibrinolytic Effects of Intermittent Pneumatic CompressionAnnals of Surgery, 1997
- Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivoBritish Journal of Haematology, 1996
- Hemodynamic and Fibrinolytic Consequences of Intermittent Pneumatic CompressionThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- Tissue factor pathway inhibitor and the current concept of blood coagulationBlood Coagulation & Fibrinolysis, 1995
- Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Journal of Clinical Investigation, 1993
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Synergism between full length TFPI and heparinBlood Coagulation & Fibrinolysis, 1992
- The C-terminus of tissue factor pathway inhibitor (TFPI) is essential to its anticoagulant activityBiochemistry, 1991
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- Heparin cofactor activity measured with an amidolytic methodThrombosis Research, 1975